Qualification of Drivers; Exemption Applications; Epilepsy and Seizure Disorders, 4763-4764 [2020-01274]

Download as PDF khammond on DSKJM1Z7X2PROD with NOTICES Federal Register / Vol. 85, No. 17 / Monday, January 27, 2020 / Notices your comments by this date in order to act quickly on the ICR. ADDRESSES: All comments should reference Federal Docket Management System (FDMS) Docket Number FMCSA–2019–0140. Interested persons are invited to submit written comments on the proposed information collection to the Office of Information and Regulatory Affairs, Office of Management and Budget. Comments should be addressed to the attention of the Desk Officer, Department of Transportation/Federal Motor Carrier Safety Administration, and sent via electronic mail to oira_submission@ omb.eop.gov, or faxed to (202) 395– 6974, or mailed to the Office of Information and Regulatory Affairs, Office of Management and Budget, Docket Library, Room 10102, 725 17th Street NW, Washington, DC 20503. FOR FURTHER INFORMATION CONTACT: Ms. Suzanne Rach, Office of Enforcement and Compliance, Hazardous Materials Division, FMCSA, West Building 6th Floor, 1200 New Jersey Avenue SE, Washington, DC 20590. Telephone: 202–385–2307; email suzanne.rach@ dot.gov. Office hours are from 9 a.m. to 5 p.m., Monday through Friday, except Federal Holidays. SUPPLEMENTARY INFORMATION: Background: The data for the Transportation of Hazardous Materials; Highway Routing ICR is collected under authority of 49 U.S.C. 5112 and 5125. Specifically, 49 U.S.C. 5112(c) requires that the Secretary, in coordination with the States, ‘‘shall update and publish periodically a list of currently effective hazardous material highway route designations.’’ In 49 CFR 397.73, FMCSA requires that each State, the District of Columbia, Indian tribes, and U.S. Territories, through its routing agency, provide information identifying new, or changes to existing, hazardous materials routing designations within its jurisdiction within 60 days after their establishment (or 60 days of the change). That information is collected and consolidated by FMCSA and published annually, in whole or as updates, in the Federal Register at https:// www.fmcsa.dot.gov/. Title: Transportation of Hazardous Materials, Highway Routing. OMB Control Number: 2126–0014. Type of Request: Extension of a currently-approved information collection. Respondents: The reporting burden is shared by 50 States, the District of Columbia, Indian tribes with designated routes, and U.S. Territories including; Puerto Rico, American Samoa, Guam, VerDate Sep<11>2014 16:54 Jan 24, 2020 Jkt 250001 the Commonwealth of the Northern Mariana Islands and the U.S. Virgin Islands. Estimated Number of Respondents: 57 [36 States + the District of Columbia, with designated hazardous materials highway routes + 19 States/U.S. Territories without designated hazardous materials highway routes + 1 Indian tribe with a designated route = 57]. Estimated Time per Response: 15 minutes. Expiration Date: April 30, 2020. Frequency of Response: Once every two years. Estimated Total Annual Burden: 7 hours [57 annual respondents × 1 response per 2 years × 15 minutes per response/60 minutes per response = 7.125 hours rounded to 7 hours]. Public Comments Invited: You are asked to comment on any aspect of this information collection, including: (1) Whether the proposed collection is necessary for the FMCSA to perform it’s functions; (2) the accuracy of the estimated burden; (3) ways for the FMCSA to enhance the quality, usefulness, and clarity of the collected information; and (4) ways that the burden could be minimized without reducing the quality of the collected information. Issued under the authority delegated in 49 CFR 1.87 on: January 17, 2020. Kelly Regal, Associate Administrator for Office of Research and Information Technology. [FR Doc. 2020–01284 Filed 1–24–20; 8:45 am] BILLING CODE 4910–EX–P DEPARTMENT OF TRANSPORTATION [Docket No. FMCSA–2019–0207] Qualification of Drivers; Exemption Applications; Epilepsy and Seizure Disorders Federal Motor Carrier Safety Administration (FMCSA), DOT. ACTION: Notice of denials. AGENCY: FMCSA announces its decision to deny applications from 41 individuals who requested an exemption from the Federal Motor Carrier Safety Regulations (FMCSRs) prohibiting persons with a clinical diagnosis of epilepsy or any other condition that is likely to cause a loss of consciousness or any loss of ability to operate a commercial motor vehicle (CMV) from operating CMVs in interstate commerce. PO 00000 Frm 00142 Fmt 4703 Sfmt 4703 Ms. Christine A. Hydock, Chief, Medical Programs Division, (202) 366–4001, fmcsamedical@dot.gov, FMCSA, Department of Transportation, 1200 New Jersey Avenue SE, Room W64–224, Washington, DC 20590–0001. Office hours are from 8:30 a.m. to 5 p.m., ET, Monday through Friday, except Federal holidays. If you have questions regarding viewing material in the docket, contact Docket Operations, (202) 366–9826. SUPPLEMENTARY INFORMATION: FOR FURTHER INFORMATION CONTACT: I. Public Participation A. Viewing Documents and Comments To view comments, as well as any documents mentioned in this notice as being available in the docket, go to https://www.regulations.gov/ docket?D=FMCSA-2019-0207 and choose the document to review. If you do not have access to the internet, you may view the docket online by visiting Docket Operations in Room W12–140 on the ground floor of the DOT West Building, 1200 New Jersey Avenue SE, Washington, DC 20590, between 9 a.m. and 5 p.m., ET, Monday through Friday, except Federal holidays. B. Privacy Act In accordance with 5 U.S.C. 553(c), DOT solicits comments from the public to better inform its rulemaking process. DOT posts these comments, without edit, including any personal information the commenter provides, to www.regulations.gov, as described in the system of records notice (DOT/ALL– 14 FDMS), which can be reviewed at www.transportation.gov/privacy. II. Background Federal Motor Carrier Safety Administration SUMMARY: 4763 FMCSA received applications from 41 individuals who requested an exemption from the FMCSRs prohibiting persons with a clinical diagnosis of epilepsy or any other condition that is likely to cause a loss of consciousness or any loss of ability to operate a CMV from operating CMVs in interstate commerce. FMCSA has evaluated the eligibility of these applicants and concluded that granting these exemptions would not provide a level of safety that would be equivalent to, or greater than, the level of safety that would be obtained by complying with § 391.41(b)(8). III. Basis for Exemption Determination Under 49 U.S.C. 31136(e) and 31315(b), FMCSA may grant an exemption from the FMCSRs for no longer than a 5-year period if it finds such exemption would likely achieve a E:\FR\FM\27JAN1.SGM 27JAN1 4764 Federal Register / Vol. 85, No. 17 / Monday, January 27, 2020 / Notices level of safety that is equivalent to, or greater than, the level that would be achieved absent such exemption. The statute also allows the Agency to renew exemptions at the end of the 5-year period. FMCSA grants medical exemptions from the FMCSRs for a 2year period to align with the maximum duration of a driver’s medical certification. The Agency’s decision regarding these exemption applications is based on the eligibility criteria, the terms and conditions for Federal exemptions, and an individualized assessment of each applicant’s medical information provided by the applicant. khammond on DSKJM1Z7X2PROD with NOTICES IV. Conclusion The Agency has determined that these applicants do not satisfy the eligibility criteria or meet the terms and conditions of the Federal exemption and granting these exemptions would not provide a level of safety that would be equivalent to, or greater than, the level of safety that would be obtained by complying with § 391.41(b)(8). Therefore, the 41 applicants in this notice have been denied exemptions from the physical qualification standards in § 391.41(b)(8). Each applicant has, prior to this notice, received a letter of final disposition regarding his/her exemption request. Those decision letters fully outlined the basis for the denial and constitute final action by the Agency. This notice summarizes the Agency’s recent denials as required under 49 U.S.C. 31315(b)(4) by periodically publishing names and reasons for denial. The following 41 applicants do not meet the minimum time requirement for being seizure-free, either on or off of anti-seizure medication: Justin Bartlett (ME) Robert Bonds (SC) Michael Bretz (MN) Theresa Buchanan (MI) Kenneth Caldwell (CA) Joseph Campbell (AK) Timothy Campbell (IN) Leslie Dillard (NC) Earnest Drummond (GA) Jackie Frolund (MN) Michael Galloway (WI) Aaron Gnoinsky (ND) Kenny Goins (TN) Michael Gravley (NV) Nathanial Harmon (WI) Dustan Hendrickson (OR) Alfonzo Hennigan (GA) Timothy Howard (NY) Billy Hunter (KY) Brian Iverson (CA) Lance Johnson (TN) Michael Kramer (KS) Kurtis Kuhl (OH) VerDate Sep<11>2014 16:54 Jan 24, 2020 Jkt 250001 Programs Division, (202) 366–4001, fmcsamedical@dot.gov, FMCSA, Department of Transportation, 1200 New Jersey Avenue SE, Room W64–224, Washington, DC 20590–0001. Office hours are from 8:30 a.m. to 5 p.m., ET, Monday through Friday, except Federal holidays. If you have questions regarding viewing or submitting material to the docket, contact Docket Operations, (202) 366–9826. SUPPLEMENTARY INFORMATION: Blake Kunkel (MN) Michael Leiterman (WI) Nicholas Liebe (WI) Robert Macarthur (MO) Brian Manning (NJ) Kevin Mast (CA) Anthony Middleton (NJ) Christopher Monsky (CT) Joshua Pittman (CA) Lee Riebe (OH) Blake Shaw (NY) Gregory Stone (SC) David Thomas (OK) Laranzo White (SC) Patrick Willis (CO) Kenneth Winn (UT) James Woltz (GA) David Wright (MA) I. Public Participation Issued on: January 17, 2020. Larry W. Minor, Associate Administrator for Policy. [FR Doc. 2020–01274 Filed 1–24–20; 8:45 am] BILLING CODE 4910–EX–P DEPARTMENT OF TRANSPORTATION Federal Motor Carrier Safety Administration [Docket No. FMCSA–1999–5578; FMCSA– 1999–5748; FMCSA–2001–10578; FMCSA– 2002–11426; FMCSA–2002–12844; FMCSA– 2003–15892; FMCSA–2003–16241; FMCSA– 2005–21711; FMCSA–2005–22194; FMCSA– 2008–0231; FMCSA–2009–0054; FMCSA– 2009–0154; FMCSA–2011–0124; FMCSA– 2011–0142; FMCSA–2011–26690; FMCSA– 2013–0025; FMCSA–2013–0027; FMCSA– 2013–0028; FMCSA–2013–0029; FMCSA– 2013–0030; FMCSA–2013–0165; FMCSA– 2013–0166; FMCSA–2013–0168; FMCSA– 2013–0169; FMCSA–2013–0170; FMCSA– 2014–0297; FMCSA–2014–0298; FMCSA– 2015–0055; FMCSA–2015–0056; FMCSA– 2015–0070; FMCSA–2015–0071; FMCSA– 2015–0072; FMCSA–2017–0019] Qualification of Drivers; Exemption Applications; Vision Federal Motor Carrier Safety Administration (FMCSA), DOT. ACTION: Notice of final disposition. AGENCY: FMCSA announces its decision to renew exemptions for 77 individuals from the vision requirement in the Federal Motor Carrier Safety Regulations (FMCSRs) for interstate commercial motor vehicle (CMV) drivers. The exemptions enable these individuals to continue to operate CMVs in interstate commerce without meeting the vision requirement in one eye. DATES: Each group of renewed exemptions were applicable on the dates stated in the discussions below and will expire on the dates provided below. FOR FURTHER INFORMATION CONTACT: Ms. Christine A. Hydock, Chief, Medical SUMMARY: PO 00000 Frm 00143 Fmt 4703 Sfmt 4703 A. Viewing Documents and Comments To view comments, as well as any documents mentioned in this notice as being available in the docket, go to https://www.regulations.gov. Insert the docket number, FMCSA–1999–5578; FMCSA–1999–5748; FMCSA–2001– 10578; FMCSA–2002–11426; FMCSA– 2002–12844; FMCSA–2003–15892; FMCSA–2003–16241; FMCSA–2005– 21711; FMCSA–2005–22194; FMCSA– 2008–0231; FMCSA–2009–0054; FMCSA–2009–0154; FMCSA–2011– 0124; FMCSA–2011–0142; FMCSA– 2011–26690; FMCSA–2013–0025; FMCSA–2013–0027; FMCSA–2013– 0028; FMCSA–2013–0029; FMCSA– 2013–0030; FMCSA–2013–0165; FMCSA–2013–0166; FMCSA–2013– 0168; FMCSA–2013–0169; FMCSA– 2013–0170; FMCSA–2014–0297; FMCSA–2014–0298; FMCSA–2015– 0055; FMCSA–2015–0056; FMCSA– 2015–0070; FMCSA–2015–0071; FMCSA–2015–0072; or FMCSA–2017– 0019, in the keyword box, and click ‘‘Search.’’ Next, click the ‘‘Open Docket Folder’’ button and choose the document to review. If you do not have access to the internet, you may view the docket online by visiting the Docket Operations in Room W12–140 on the ground floor of the DOT West Building, 1200 New Jersey Avenue SE, Washington, DC 20590, between 9 a.m. and 5 p.m., ET, Monday through Friday, except Federal holidays. B. Privacy Act In accordance with 5 U.S.C. 553(c), DOT solicits comments from the public to better inform its rulemaking process. DOT posts these comments, without edit, including any personal information the commenter provides, to www.regulations.gov, as described in the system of records notice (DOT/ALL– 14 FDMS), which can be reviewed at www.transportation.gov/privacy. II. Background On December 4, 2019, FMCSA published a notice announcing its decision to renew exemptions for 77 E:\FR\FM\27JAN1.SGM 27JAN1

Agencies

[Federal Register Volume 85, Number 17 (Monday, January 27, 2020)]
[Notices]
[Pages 4763-4764]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-01274]


-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Motor Carrier Safety Administration

[Docket No. FMCSA-2019-0207]


Qualification of Drivers; Exemption Applications; Epilepsy and 
Seizure Disorders

AGENCY: Federal Motor Carrier Safety Administration (FMCSA), DOT.

ACTION: Notice of denials.

-----------------------------------------------------------------------

SUMMARY: FMCSA announces its decision to deny applications from 41 
individuals who requested an exemption from the Federal Motor Carrier 
Safety Regulations (FMCSRs) prohibiting persons with a clinical 
diagnosis of epilepsy or any other condition that is likely to cause a 
loss of consciousness or any loss of ability to operate a commercial 
motor vehicle (CMV) from operating CMVs in interstate commerce.

FOR FURTHER INFORMATION CONTACT: Ms. Christine A. Hydock, Chief, 
Medical Programs Division, (202) 366-4001, fmcsa[email protected], FMCSA, 
Department of Transportation, 1200 New Jersey Avenue SE, Room W64-224, 
Washington, DC 20590-0001. Office hours are from 8:30 a.m. to 5 p.m., 
ET, Monday through Friday, except Federal holidays. If you have 
questions regarding viewing material in the docket, contact Docket 
Operations, (202) 366-9826.

SUPPLEMENTARY INFORMATION:

I. Public Participation

A. Viewing Documents and Comments

    To view comments, as well as any documents mentioned in this notice 
as being available in the docket, go to https://www.regulations.gov/docket?D=FMCSA-2019-0207 and choose the document to review. If you do 
not have access to the internet, you may view the docket online by 
visiting Docket Operations in Room W12-140 on the ground floor of the 
DOT West Building, 1200 New Jersey Avenue SE, Washington, DC 20590, 
between 9 a.m. and 5 p.m., ET, Monday through Friday, except Federal 
holidays.

B. Privacy Act

    In accordance with 5 U.S.C. 553(c), DOT solicits comments from the 
public to better inform its rulemaking process. DOT posts these 
comments, without edit, including any personal information the 
commenter provides, to www.regulations.gov, as described in the system 
of records notice (DOT/ALL-14 FDMS), which can be reviewed at 
www.transportation.gov/privacy.

II. Background

    FMCSA received applications from 41 individuals who requested an 
exemption from the FMCSRs prohibiting persons with a clinical diagnosis 
of epilepsy or any other condition that is likely to cause a loss of 
consciousness or any loss of ability to operate a CMV from operating 
CMVs in interstate commerce.
    FMCSA has evaluated the eligibility of these applicants and 
concluded that granting these exemptions would not provide a level of 
safety that would be equivalent to, or greater than, the level of 
safety that would be obtained by complying with Sec.  391.41(b)(8).

III. Basis for Exemption Determination

    Under 49 U.S.C. 31136(e) and 31315(b), FMCSA may grant an exemption 
from the FMCSRs for no longer than a 5-year period if it finds such 
exemption would likely achieve a

[[Page 4764]]

level of safety that is equivalent to, or greater than, the level that 
would be achieved absent such exemption. The statute also allows the 
Agency to renew exemptions at the end of the 5-year period. FMCSA 
grants medical exemptions from the FMCSRs for a 2-year period to align 
with the maximum duration of a driver's medical certification. The 
Agency's decision regarding these exemption applications is based on 
the eligibility criteria, the terms and conditions for Federal 
exemptions, and an individualized assessment of each applicant's 
medical information provided by the applicant.

IV. Conclusion

    The Agency has determined that these applicants do not satisfy the 
eligibility criteria or meet the terms and conditions of the Federal 
exemption and granting these exemptions would not provide a level of 
safety that would be equivalent to, or greater than, the level of 
safety that would be obtained by complying with Sec.  391.41(b)(8). 
Therefore, the 41 applicants in this notice have been denied exemptions 
from the physical qualification standards in Sec.  391.41(b)(8).
    Each applicant has, prior to this notice, received a letter of 
final disposition regarding his/her exemption request. Those decision 
letters fully outlined the basis for the denial and constitute final 
action by the Agency. This notice summarizes the Agency's recent 
denials as required under 49 U.S.C. 31315(b)(4) by periodically 
publishing names and reasons for denial.
    The following 41 applicants do not meet the minimum time 
requirement for being seizure-free, either on or off of anti-seizure 
medication:

Justin Bartlett (ME)
Robert Bonds (SC)
Michael Bretz (MN)
Theresa Buchanan (MI)
Kenneth Caldwell (CA)
Joseph Campbell (AK)
Timothy Campbell (IN)
Leslie Dillard (NC)
Earnest Drummond (GA)
Jackie Frolund (MN)
Michael Galloway (WI)
Aaron Gnoinsky (ND)
Kenny Goins (TN)
Michael Gravley (NV)
Nathanial Harmon (WI)
Dustan Hendrickson (OR)
Alfonzo Hennigan (GA)
Timothy Howard (NY)
Billy Hunter (KY)
Brian Iverson (CA)
Lance Johnson (TN)
Michael Kramer (KS)
Kurtis Kuhl (OH)
Blake Kunkel (MN)
Michael Leiterman (WI)
Nicholas Liebe (WI)
Robert Macarthur (MO)
Brian Manning (NJ)
Kevin Mast (CA)
Anthony Middleton (NJ)
Christopher Monsky (CT)
Joshua Pittman (CA)
Lee Riebe (OH)
Blake Shaw (NY)
Gregory Stone (SC)
David Thomas (OK)
Laranzo White (SC)
Patrick Willis (CO)
Kenneth Winn (UT)
James Woltz (GA)
David Wright (MA)


    Issued on: January 17, 2020.
Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2020-01274 Filed 1-24-20; 8:45 am]
 BILLING CODE 4910-EX-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.